Info

Indigene, a rapidly growing biopharmaceutical company, was founded in 2002 with a strategic focus to rapidly develop and deliver innovative, safe, and effective molecular combination based healthcare products. We call this unique offering Multiceutics. These molecular combinations are optimized to work simultaneously on multiple pathways associated with diseases and symptoms of the human body. This unique product development approach results in smarter medicines, as compared to the traditional Pharma industry approach of using a single molecule to target a single pathway among the network of multiple pathways that are associated with diseases and symptoms. We believe that Indigene is at the forefront of an emerging trend in the Pharmaceutical industry toward developing molecular combination based drugs. Combining our vision, passion, and commitment with our customer and product focused business model, we have made significant advances in developing our extensive knowledge base, proprietary multiplex molecular technology platform, new products, and a sustainable innovative product pipeline. Our immediate goal is to continue to leverage our core company strengths in the USA, Canada, Europe, and India; and to globally launch a series of unique products in both Consumer Healthcare (CHC) and Prescription Drug (Rx) markets. Ultimately, our end goal is to have Indigene recognized as a major market contributor in developing and delivering innovative and scientifically advanced products that seek to improve the overall health and quality of human life.